Clal Biotechnology (Israel) Probability of Future Stock Price Finishing Over 38.81
| CBI Stock | 35.40 0.30 0.84% |
Clal |
Clal Biotechnology Target Price Odds to finish over 38.81
The tendency of Clal Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 38.81 or more in 90 days |
| 35.40 | 90 days | 38.81 | about 41.25 |
Based on a normal probability distribution, the odds of Clal Biotechnology to move over 38.81 or more in 90 days from now is about 41.25 (This Clal Biotechnology Industries probability density function shows the probability of Clal Stock to fall within a particular range of prices over 90 days) . Probability of Clal Biotechnology price to stay between its current price of 35.40 and 38.81 at the end of the 90-day period is about 51.96 .
Assuming the 90 days trading horizon Clal Biotechnology has a beta of 0.2 suggesting as returns on the market go up, Clal Biotechnology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Clal Biotechnology Industries will be expected to be much smaller as well. Additionally Clal Biotechnology Industries has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Clal Biotechnology Price Density |
| Price |
Predictive Modules for Clal Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clal Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Clal Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Clal Biotechnology is not an exception. The market had few large corrections towards the Clal Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Clal Biotechnology Industries, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Clal Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 1.99 | |
Ir | Information ratio | -0.06 |
Clal Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clal Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clal Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Clal Biotechnology generated a negative expected return over the last 90 days | |
| Clal Biotechnology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 76.96 M. Net Loss for the year was (89.58 M) with profit before overhead, payroll, taxes, and interest of 10.72 M. | |
| Clal Biotechnology Industries has accumulated about 94.71 M in cash with (41.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59. | |
| Roughly 65.0% of the company shares are held by company insiders |
Clal Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Clal Stock often depends not only on the future outlook of the current and potential Clal Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clal Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 161.1 M | |
| Dividends Paid | 36 M | |
| Forward Annual Dividend Rate | 0.22 |
Clal Biotechnology Technical Analysis
Clal Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Clal Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Clal Biotechnology Industries. In general, you should focus on analyzing Clal Stock price patterns and their correlations with different microeconomic environments and drivers.
Clal Biotechnology Predictive Forecast Models
Clal Biotechnology's time-series forecasting models is one of many Clal Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Clal Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Clal Biotechnology
Checking the ongoing alerts about Clal Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Clal Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Clal Biotechnology generated a negative expected return over the last 90 days | |
| Clal Biotechnology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 76.96 M. Net Loss for the year was (89.58 M) with profit before overhead, payroll, taxes, and interest of 10.72 M. | |
| Clal Biotechnology Industries has accumulated about 94.71 M in cash with (41.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59. | |
| Roughly 65.0% of the company shares are held by company insiders |
Other Information on Investing in Clal Stock
Clal Biotechnology financial ratios help investors to determine whether Clal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clal with respect to the benefits of owning Clal Biotechnology security.